Stiros Tablet (Clonixin Lysinate)

Adult dose

○ Adults: Administer 125 ∼ 250 mg of clonixin lysinate orally 3 times daily.

This medication may cause gastrointestinal bleeding if taken by individuals who regularly consume more than three alcoholic drinks per day; therefore, consultation with a doctor or pharmacist is essential. It may affect the cardiovascular system and increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke, so patients with cardiovascular disease or risk factors should be closely monitored. As a non-steroidal anti-inflammatory drug (NSAID), this medication can cause serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforations, especially in the elderly or those taking it for an extended period. Patients with peptic ulcers, allergies to this medication or its components, or hypersensitivity to aspirin or similar medications should not take this medication. Pregnant women or those who could become pregnant, patients with severe liver or kidney disease, heart failure, inflammatory bowel disease, etc. should avoid taking this medication. Caution is required when used in combination with other NSAIDs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, cyclosporine, tacrolimus, antiplatelet drugs, corticosteroids, and others as the risk of side effects may increase. Children, the elderly, patients with hypertension, bronchial asthma, and individuals with liver or kidney dysfunction should consult healthcare personnel before taking this medication. While using this medication, if symptoms such as gastrointestinal bleeding, skin rashes, difficulty breathing, abnormal liver function, or blood abnormalities occur, discontinue use immediately and consult healthcare personnel. It is recommended to stop breastfeeding or discontinue this medication when administering it to breastfeeding women as it may cause adverse reactions in the baby. Use the lowest effective dose for the shortest duration possible, and patients with chronic diseases should undergo regular blood tests and liver/kidney function assessments. This medication is a symptomatic treatment for reducing inflammation and pain and should not replace the underlying treatment when needed.

Gastrointestinal bleeding, severe cardiovascular thromboembolic reactions, myocardial infarction, stroke, bleeding of the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, abnormal euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, fluid retention, edema, renal papillary necrosis, mucocutaneous syndrome, toxic epidermal necrolysis, exfoliative dermatitis, anaphylactoid reaction, severe bronchospasm

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for an extended period.

Appearance

Sky blue round coated tablet

Package unit

100 tablets/box (10 tablets/strip x 10)